pyrroles has been researched along with Encapsulating Peritoneal Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Deng, H; Huang, H; Ji, S; Jin, W; Shen, J; Shen, Q; Tang, H; Yan, P; Zhang, J; Zhao, X | 1 |
| Akar, H; Kolatan, E; Meteoglu, I; Sarioglu, S; Uzelce, O; Yeniçerioglu, Y; Yenisey, C; Yilmaz, O | 1 |
2 other study(ies) available for pyrroles and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Tamoxifen attenuates dialysate-induced peritoneal fibrosis by inhibiting GSK-3β/β-catenin axis activation.
Topics: Animals; beta Catenin; Disease Models, Animal; Epithelial-Mesenchymal Transition; Gene Expression Regulation; Glucose; Glycogen Synthase Kinase 3 beta; Humans; Matrix Metalloproteinase 9; Mice; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Phosphorylation; Pyrimidines; Pyrroles; Snail Family Transcription Factors; Tamoxifen | 2018 |
Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis.
Topics: Animals; Atorvastatin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Peritoneal Dialysis; Peritoneal Fibrosis; Peritoneum; Pyrroles; Rats; Rats, Wistar | 2010 |